Forbes contributors publish independent expert analyses and insights. Dario Sabaghi covers the cannabis industry with a focus on Europe. This voice experience is generated by AI. Learn more. This ...

Marijuana was placed in Schedule I of the Controlled Substances Act when the bill was signed into law in 1970. The Controlled Substances Act classifies drugs according to their alleged potential for ...

President Donald Trump's executive order rescheduling marijuana from a Schedule I to Schedule III substance is currently being considered by the Drug Enforcement Administration (DEA) in a formal ...

©2026 Fox News Network, LLC. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. All market data delayed 20 minutes.

A biopharmaceutical company involved in developing drugs derived from cannabinoids, as well as several doctors and groups opposed to cannabis reform, have sued the Trump administration over its plans ...

Add Yahoo as a preferred source to see more of our stories on Google. Alabama State Health Officer Dr. Scott Harris speaking at the State Committee on Public Health meeting on April 9, 2025, in the ...

Startup Assort Health developed an outbound AI agent that can proactively reach out to patients to automate appointment rescheduling, close open referrals, tackle payment collections and accelerate ...

To some degree, there may have been "buy the rumor, sell the news" at play in cannabis stocks with the rescheduling news. However, it's not surprising that the market quickly went from bullish to ...

LAS VEGAS (FOX5) — In Nevada, there are more than 100 marijuana dispensaries in operation but the drug remains classified under federal guidelines as Schedule 1, the same level as heroin. Last week, ...

North Texas dispensaries and even universities could be impacted by a federal reclassification of medical marijuana. On Thursday, acting Attorney General Todd Blanche signed an order reclassifying ...

The Justice Department on Thursday announced it would issue a final order immediately reclassifying Federal Drug Administration-approved drugs and state-approved medical products as Schedule III ...